Minerva Neurosciences Inc expected to post a loss of 92 cents a share - Earnings Preview

Minerva Neurosciences

24/02/2023 18:20

* Minerva Neurosciences Inc  NERV.OQ   NERV.O  is expected
to show
no change in quarterly revenue when it reports  results on
February 27 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Minerva
Neurosciences Inc
is for a loss of 92 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Minerva
Neurosciences Inc is $7​, above​ its last closing price
of $2.30. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -1.04       -1.32      -1.29     Beat    2.1
 Jun. 30 2022  -1.66       -1.65      -1.63     Beat    1.4
 Mar. 31 2022  -1.43       -1.48      -1.84     Missed  -24.3​
 Dec. 31 2021  -1.52       -1.50      -4.00     Missed  -166.7
 ​​Sep.        -1.89       -1.76      -1.76     Met     0
 30 2021                                                
 Jun. 30 2021  -1.42       -1.39      -2.00     Missed  -43.7​
 Mar. 31 2021  -0.32       2.66       -1.44     Missed  -154.2
 Dec. 31 2020  -1.40       -1.53      -1.44     Beat    6.1
 This summary was machine generated February 24 at 18:20 GMT. 
All figures in US dollars  unless otherwise stated